A detailed history of Northern Trust Corp transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Northern Trust Corp holds 244,519 shares of KOD stock, worth $650,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,519
Previous 256,919 4.83%
Holding current value
$650,420
Previous $1.35 Million 57.51%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $28,396 - $55,552
-12,400 Reduced 4.83%
244,519 $574,000
Q1 2024

May 14, 2024

BUY
$3.01 - $7.45 $7,422 - $18,371
2,466 Added 0.97%
256,919 $1.35 Million
Q4 2023

Feb 13, 2024

SELL
$1.4 - $3.24 $9,689 - $22,424
-6,921 Reduced 2.65%
254,453 $773,000
Q3 2023

Nov 13, 2023

BUY
$1.8 - $7.49 $2,217 - $9,227
1,232 Added 0.47%
261,374 $470,000
Q2 2023

Aug 11, 2023

SELL
$4.3 - $9.48 $103,131 - $227,368
-23,984 Reduced 8.44%
260,142 $1.79 Million
Q1 2023

May 15, 2023

SELL
$4.81 - $8.88 $54,280 - $100,210
-11,285 Reduced 3.82%
284,126 $1.76 Million
Q4 2022

Feb 13, 2023

BUY
$6.52 - $8.05 $12,740 - $15,729
1,954 Added 0.67%
295,411 $2.12 Million
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $58,909 - $97,275
-7,782 Reduced 2.58%
293,457 $2.27 Million
Q2 2022

Aug 12, 2022

SELL
$5.04 - $9.48 $75,675 - $142,342
-15,015 Reduced 4.75%
301,239 $2.3 Million
Q1 2022

May 13, 2022

SELL
$7.09 - $89.45 $97,409 - $1.23 Million
-13,739 Reduced 4.16%
316,254 $2.44 Million
Q4 2021

Feb 08, 2022

SELL
$80.85 - $128.49 $337,629 - $536,574
-4,176 Reduced 1.25%
329,993 $28 Million
Q3 2021

Nov 15, 2021

SELL
$81.97 - $106.94 $1.22 Million - $1.59 Million
-14,899 Reduced 4.27%
334,169 $32.1 Million
Q2 2021

Aug 13, 2021

SELL
$77.2 - $126.54 $1.15 Million - $1.88 Million
-14,879 Reduced 4.09%
349,068 $32.5 Million
Q1 2021

May 12, 2021

SELL
$110.45 - $164.47 $1.08 Million - $1.6 Million
-9,749 Reduced 2.61%
363,947 $41.3 Million
Q4 2020

Feb 11, 2021

BUY
$60.78 - $154.03 $2.32 Million - $5.87 Million
38,107 Added 11.36%
373,696 $54.9 Million
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $892,440 - $1.17 Million
-19,810 Reduced 5.57%
335,589 $19.9 Million
Q2 2020

Aug 14, 2020

BUY
$42.74 - $66.25 $795,733 - $1.23 Million
18,618 Added 5.53%
355,399 $19.2 Million
Q1 2020

May 14, 2020

BUY
$38.18 - $73.95 $1.69 Million - $3.27 Million
44,282 Added 15.14%
336,781 $16.1 Million
Q4 2019

Feb 14, 2020

BUY
$13.9 - $76.65 $394,940 - $2.18 Million
28,413 Added 10.76%
292,499 $21 Million
Q3 2019

Nov 13, 2019

BUY
$10.24 - $17.57 $1.57 Million - $2.69 Million
152,893 Added 137.5%
264,086 $3.8 Million
Q2 2019

Aug 13, 2019

BUY
$6.2 - $12.0 $145,545 - $281,700
23,475 Added 26.76%
111,193 $1.3 Million
Q1 2019

May 13, 2019

BUY
$6.43 - $9.44 $122,369 - $179,652
19,031 Added 27.71%
87,718 $573,000
Q4 2018

Feb 12, 2019

BUY
$6.11 - $10.43 $419,677 - $716,405
68,687 New
68,687 $487,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $138M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.